In practice, 5-FU causes base lesions that promote replication fork stalling in proliferating cancer cells, and HMGA2 overexpression is associated with 5-FU chemoresistance in CRC patients [141]. This evidence concerns the gene HMGA2 and colorectal carcinoma.